155 related articles for article (PubMed ID: 3311208)
1. Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow.
Welte K; Keever CA; Levick J; Bonilla MA; Merluzzi VJ; Mertelsmann R; Evans R; O'Reilly RJ
Blood; 1987 Nov; 70(5):1595-603. PubMed ID: 3311208
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
Keever CA; Welte K; Small T; Levick J; Sullivan M; Hauch M; Evans RL; O'Reilly RJ
Blood; 1987 Dec; 70(6):1893-903. PubMed ID: 3118990
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
Blood; 1990 May; 75(10):2076-84. PubMed ID: 1970938
[TBL] [Abstract][Full Text] [Related]
4. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
Ozerol I; Ageitos A; Heimann DG; Talmadge JE
Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Murray C; Gonin R; Ritz J
Blood; 1994 Aug; 84(3):964-71. PubMed ID: 8043878
[TBL] [Abstract][Full Text] [Related]
6. Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2.
Welte K; Ciobanu N; Moore MA; Gulati S; O'Reilly RJ; Mertelsmann R
Blood; 1984 Aug; 64(2):380-5. PubMed ID: 6378275
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Murray C; Cochran K; Cameron C; Wang E; Schow PW; Daley JF; Ritz J
Blood; 1992 Jan; 79(2):517-26. PubMed ID: 1730094
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 production following T-cell-depleted and unmodified marrow grafts.
Sahdev I; O'Reilly R; Black P; Heller G; Hoffmann M
Pediatr Hematol Oncol; 1996; 13(1):55-67. PubMed ID: 8718503
[TBL] [Abstract][Full Text] [Related]
9. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
10. Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.
Katsanis E; Anderson PM; Filipovich AH; Hasz DE; Rich ML; Loeffler CM; Ochoa AC; Weisdorf DJ
Blood; 1991 Sep; 78(5):1286-91. PubMed ID: 1831682
[TBL] [Abstract][Full Text] [Related]
11. Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.
Benkerrou M; Wara DW; Elder M; Dror Y; Merino A; Colombe BW; Garovoy M; Cowan MJ
J Clin Immunol; 1994 Mar; 14(2):98-106. PubMed ID: 8195318
[TBL] [Abstract][Full Text] [Related]
12. Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation.
Izquierdo M; Balboa MA; Fernández-Rañada JM; Figuera A; Torres A; Iriondo A; López-Botet M
Clin Exp Immunol; 1990 Oct; 82(1):145-50. PubMed ID: 1698579
[TBL] [Abstract][Full Text] [Related]
13. Characterization of circulating suppressor T lymphocytes in bone marrow transplant recipients.
Gebel HM; Kaizer H; Landay AL
Transplantation; 1987 Feb; 43(2):258-63. PubMed ID: 2949405
[TBL] [Abstract][Full Text] [Related]
14. Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy.
Pavletic Z; Benyunes MC; Thompson JA; Lindgren CG; Massumoto C; Alderson MR; Buckner CD; Fefer A
Exp Hematol; 1993 Sep; 21(10):1371-8. PubMed ID: 8359237
[TBL] [Abstract][Full Text] [Related]
15. Soybean agglutinin-positive natural suppressor cells in mouse bone marrow inhibit interleukin 2 production and utilization in mixed lymphocyte reactions.
Hoskin DW; Bowser DA; Brooks-Kaiser JC
J Leukoc Biol; 1992 Jun; 51(6):649-56. PubMed ID: 1535357
[TBL] [Abstract][Full Text] [Related]
16. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.
Keever CA; Small TN; Flomenberg N; Heller G; Pekle K; Black P; Pecora A; Gillio A; Kernan NA; O'Reilly RJ
Blood; 1989 Apr; 73(5):1340-50. PubMed ID: 2649174
[TBL] [Abstract][Full Text] [Related]
17. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Kedar E; Or R; Naparstek E; Zeira E; Slavin S
Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine production by T-cell clones after human bone marrow transplantation.
Velardi A; Varese P; Terenzi A; Dembech C; Albi N; Grossi CE; Moretta L; Martelli MF; Grignani F; Mingari MC
Blood; 1989 Oct; 74(5):1665-72. PubMed ID: 2506949
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 induces interferon alpha/beta production in mouse bone marrow cells.
Reyes VE; Ballas ZK; Singh H; Klimpel GR
Cell Immunol; 1986 Oct; 102(2):374-85. PubMed ID: 3100059
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
Woolfrey AE; Neudorf S; Filipovich AH
Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
